Insulin aspart, recombinant Subcutaneous and Trabectedin Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Trabectedin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: trabectedin
Brand name: Yondelis
Synonyms: Trabectedin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Trace Elements
- Insulin aspart, recombinant Subcutaneous-Trace Elements 4 Injection
- Insulin aspart, recombinant Subcutaneous-Tracleer
- Insulin aspart, recombinant Subcutaneous-Tracleer (Bosentan Tablets for Oral Suspension)
- Insulin aspart, recombinant Subcutaneous-Tracleer (Bosentan Tablets)
- Insulin aspart, recombinant Subcutaneous-Tradjenta
- Trabectedin Intravenous-Insulin degludec
- Trabectedin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Trabectedin Intravenous-Insulin Degludec (U-100) Vials
- Trabectedin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Trabectedin Intravenous-Insulin degludec and liraglutide
- Trabectedin Intravenous-Insulin degludec and liraglutide Subcutaneous